Endologix Says Cook Infringement Suit is Not Valid

 

October 14, 2009

October 14, 2009 – Endologix Inc., developer of minimally invasive treatments for aortic disorders, said yesterday it evaluated the patent infringement lawsuit filed against the company last week by Cook Medical and says the suit is without merit.

Endologix said it intends to vigorously defend its position. "We are pleased that our initial evaluation of these claims, which Cook Medical waited for years to assert, has already yielded support for numerous promising defenses," said John McDermott, Endologix president and CEO.

Endologix flagship product is the Powerlink System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA).

For more information: www.endologix.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.